Cost-benefit analysis of capecitabine versus 5-fluorouracil/leucovorin in the treatment of colorectal cancer in the Netherlands (Q44931008)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-benefit analysis of capecitabine versus 5-fluorouracil/leucovorin in the treatment of colorectal cancer in the Netherlands |
scientific article |
Statements
1 reference
Cost-benefit analysis of capecitabine versus 5-fluorouracil/leucovorin in the treatment of colorectal cancer in the Netherlands (English)
1 reference
Maarten J Postma
1 reference
Frank G A Jansman
1 reference
David van Hartskamp
1 reference
Pax H B Willemse
1 reference
Jacobus R B J Brouwers
1 reference
1 April 2004
1 reference
1 reference
26
1 reference
4
1 reference
579-589
1 reference
Identifiers
1 reference
1 reference